Tag: IVF

  • Public funding for single embryo transfer cuts multifetal pregnancy rates in IVF

    Public funding for single embryo transfer cuts multifetal pregnancy rates in IVF

    [ad_1]

    In the era after the introduction of publicly funded in vitro fertilization (IVF) mandating elective single embryo transfer, the multifetal pregnancy rate decreased significantly for IVF, but the contribution of ovulation induction and intrauterine insemination (OI/IUI) to multifetal pregnancy still needs attention, according to a new study from ICES and Queen’s University. 

    Twins, triplets, and higher multifetal pregnancies are associated with some adverse outcomes in pregnancy and childbirth. Fertility treatments such as IVF and ovulation induction and intrauterine insemination (OI/IUI) are more likely to result in a multifetal pregnancy. In Canada, Ontario’s publicly funded fertility program mandated the use of elective single embryo transfer (eSET) in 2015. 

    In a new study from the journal JAMA Network Open, researchers evaluated the association between fertility treatment and multifetal pregnancies in Ontario for over 1 million pregnancies between 2006 and 2021. This is one of the first studies to include all forms of fertility treatments and accounted for fetal reductions that may have been performed earlier in a pregnancy. 

    While we found a substantial decrease in multifetal pregnancy rates for IVF after the mandate was introduced, we didn’t see the same decrease after OI/IUI. It’s more difficult to regulate multifetal pregnancies with this type of fertility treatment, because the type of protocols used and adherence to specific cancellation criteria may differ across clinics.” 

    Maria Velez, lead author, adjunct scientist at ICES and associate professor in the department of Obstetrics and Gynaecology at Queen’s University

    Of the total number of pregnancies, 96.9% were from unassisted conception, 1.4% from OI/IUI and 1.7% from IVF. Compared to those who had unassisted conception, people who received fertility treatments tended to be older, lived in higher-income communities, and had more preexisting health conditions. 

    The overall rate of multifetal pregnancies declined from 2006 to 2021, but the decrease was greater for IVF pregnancies than for those conceived by OI/IUI. When comparing the time periods before and after the eSET mandate, the rate of multifetal pregnancies declined from 13% to 9% with OI/IUI, and from 29% to 7% with IVF. 

    Improvements in assisted reproductive technology (ART) have also influenced rates of multifetal pregnancies. Advances in technologies such as embryo culture media and elective freezing of all available embryos means higher success rates for pregnancy. 

    However, the authors say that “Future studies should address the cost-effectiveness of providing 1 vs multiple publicly funded IVF cycles, especially because some couples in Ontario still pursue privately paid IVF cycles, which can result in a higher rate of multifetal pregnancy and an inherently higher risk of maternal and neonatal morbidity.” 

    One limitation of the study was the lack of detail about those who underwent fetal reduction. The data also did not capture information about the type of medication used for OI/IUI, and IVF cycles would have included both private and publicly funded treatments. 

    Nevertheless, the findings show that changes to assisted reproductive technology and the introduction of a publicly funded IVF program in Ontario both contributed to a decrease in the risk of multifetal pregnancy. 

    “Future work should address the higher risk associated with OI/IUI, and changes may be needed to standardize protocols and cancellation policies,” says Velez. 

    Source:

    Journal reference:

    Velez, M. P., et al. (2024). Multifetal Pregnancy After Implementation of a Publicly Funded Fertility Program. JAMA Network Open. doi.org/10.1001/jamanetworkopen.2024.8496.

    [ad_2]

    Source link

  • Conservative justices stir trouble for Republican politicians on abortion

    Conservative justices stir trouble for Republican politicians on abortion

    [ad_1]

    Abortion opponents have maneuvered in courthouses for years to end access to reproductive health care. In Arizona last week, a win for the anti-abortion camp caused political blowback for Republican candidates in the state and beyond.

    The reaction echoed the response to an Alabama Supreme Court decision over in vitro fertilization just two months before.

    The election-year ruling by the Arizona Supreme Court allowing enforcement of a law from 1864 banning nearly all abortions startled Republican politicians, some of whom quickly turned to social media to denounce it.

    The court decision was yet another development forcing many Republicans legislators and candidates to thread the needle: Maintain support among anti-abortion voters while not damaging their electoral prospects this fall. This shifting power dynamic between state judges and state lawmakers has turned into a high-stakes political gamble, at times causing daunting problems, on a range of reproductive health issues, for Republican candidates up and down the ballot.

    When the U.S. Supreme Court said give it back to the states, OK, well now the microscope is on the states. We saw this in Alabama with the IVF decision,” she said, “and now we’re seeing it in Arizona.”


    Jennifer Piatt, co-director of the Center for Public Health Law and Policy at Arizona State University’s Sandra Day O’Connor College of Law

    Multiple Republicans have criticized the Arizona high court’s decision on the 1864 law, which allows abortion only to save a pregnant woman’s life. “This decision cannot stand. I categorically reject rolling back the clock to a time when slavery was still legal and where we could lock up women and doctors because of an abortion,” state Rep. Matt Gress said in a video April 9. All four Arizona Supreme Court justices who said the long-dormant Arizona abortion ban could be enforced were appointed by former Gov. Doug Ducey, a Republican who in 2016 expanded the number of state Supreme Court justices from five to seven and cemented the bench’s conservative majority.

    Yet in a post the day of the ruling on the social platform X, Ducey said the decision “is not the outcome I would have preferred.”

    The irony is that the decision came after years of efforts by Arizona Republicans “to lock in a conservative majority on the court at the same time that the state’s politics were shifting more towards the middle,” said Douglas Keith, senior counsel at the left-leaning Brennan Center for Justice.

    All the while, anti-abortion groups have been pressuring Republicans to clearly define where they stand.

    “Whether running for office at the state or federal level, Arizona Republicans cannot adopt the losing ostrich strategy of burying their heads in the sand on the issue of abortion and allowing Democrats to define them,” Kelsey Pritchard, a spokesperson for Susan B. Anthony Pro-Life America, said in an emailed statement. “To win, Republicans must be clear on the pro-life protections they support, express compassion for women and unborn children, and contrast their position with the Democrat agenda.”

    Two months before the Arizona decision, the Alabama Supreme Court said frozen embryos from in vitro fertilization can be considered children under state law. The decision prompted clinics across the state to halt fertility treatments and caused a nationwide uproar over reproductive health rights. With Republicans feeling the heat, Alabama lawmakers scrambled to pass a law to shield IVF providers from prosecution and civil lawsuits “for the damage to or death of an embryo” during treatment.

    But when it comes to courts, Arizona lawmakers are doubling down: state Supreme Court justices are appointed by the governor but generally face voters every six years in retention elections. That could soon change. A constitutional amendment referred by the Arizona Legislature that could appear on the November ballot would eliminate those regular elections — triggering them only under limited circumstances — and allow the justices to serve as long as they exhibit “good behavior.” Effectively it would grant justices lifetime appointments until age 70, when they must retire.

    Even with the backlash against the Arizona court’s abortion decision, Keith said, “I suspect there aren’t Republicans in the state right now who are lamenting all these changes to entrench a conservative majority on the Supreme Court.”

    Meanwhile, abortion rights groups are trying to get a voter-led state constitutional amendment on the ballot that would protect abortion access until fetal viability and allow abortions afterward to protect the life or health of the pregnant person.

    State court decisions are causing headaches even at the very top of the Republican ticket. In an announcement in which he declined to endorse a national abortion ban, presumptive Republican presidential nominee Donald Trump on April 8 said he was “proudly the person responsible” for ending Roe v. Wade, which recognized a federal constitutional right to abortion before being overturned by the U.S. Supreme Court in 2022, and said the issue should be left to states. “The states will determine by vote or legislation, or perhaps both, and whatever they decide must be the law of the land,” he said. But just two days later he sought to distance himself from the Arizona decision. Trump also praised the Alabama Legislature for enacting the law aiming to preserve access to fertility treatments. “The Republican Party should always be on the side of the miracle of life,” he said.

    Recent court decisions on reproductive health issues in Alabama, Arizona, and Florida will hardly be the last. The Iowa Supreme Court, which underwent a conservative overhaul in recent years, on April 11 heard arguments on the state’s near-total abortion ban. Republican Gov. Kim Reynolds signed it into law in 2023 but it has been blocked in court.

    In Florida, there was disappointment all around after dueling state Supreme Court decisions this month that simultaneously paved the way for a near-total abortion ban and also allowed a ballot measure that would enshrine abortion rights in the state constitution to proceed.

    The Florida high court’s decisions were “simply unacceptable when five of the current seven sitting justices on the court were appointed by Republican Governor Ron DeSantis,” Andrew Shirvell, executive director of the anti-abortion group Florida Voice for the Unborn, said in a statement. “Clearly, grassroots pro-life advocates have been misled by elements within the ‘pro-life, pro-family establishment’ because Florida’s highest court has now revealed itself to be a paper tiger when it comes to standing-up to the murderous abortion industry.”

    Tension between state judicial systems and conservative legislators seems destined to continue given judges’ growing power over reproductive health access, Piatt said, with people on both sides of the political aisle asking: “Is this a court that is potentially going to give me politically what I’m looking for?”




    Kaiser Health NewsThis article was reprinted from khn.org, a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF – the independent source for health policy research, polling, and journalism.

    [ad_2]

    Source link

  • New study reveals lifestyle factors boosting IVF success

    New study reveals lifestyle factors boosting IVF success

    [ad_1]

    In a recent study published in the journal Frontiers in Endocrinology, researchers examined how lifestyle factors and fertility-specific quality of life (QOL) influence the outcomes of assisted reproductive technology (ART) treatments.

    Study: Lifestyle and fertility-specific quality of life affect reproductive outcomes in couples undergoing in vitro fertilization. Image Credit: Corona Borealis Studio / ShutterstockStudy: Lifestyle and fertility-specific quality of life affect reproductive outcomes in couples undergoing in vitro fertilization. Image Credit: Corona Borealis Studio / Shutterstock

    Background 

    Infertility impacts around 48.5 million couples worldwide, leading to an increase in ART treatments, with 2.5-3 million cycles annually and nearly 450,000 in Japan alone. With 1 in every 13.9 Japanese babies born via ART, the influence of factors like age, ovarian reserve, and lifestyle choices- including diet, smoking, exercise, and sleep- on treatment success is recognized. The World Health Organization (WHO) highlights the need to assess QOL, including fertility-specific QOL, via tools like the Fertility Quality of Life tool (FertiQoL). The relationship between fertility-specific QOL and ART outcomes, however, requires further research to understand their complex interactions better.

    About the study 

    The present study focused on infertile couples undergoing their first in vitro fertilization (IVF) treatment in Japan, selecting participants based on specific health and demographic criteria. At the outset, participants detailed their dietary habits, modeled after the Mediterranean diet but tailored to Japanese preferences, and lifestyle choices, including sleep patterns, work habits, computer usage, smoking status, and physical activity, measured by metabolic equivalent tasks (METs). Additionally, the fertility-specific quality of life was assessed using the Japanese version of the FertiQoL questionnaire, exploring its influence on treatment outcomes.

    The study outlined the protocols for controlled ovarian stimulation, laboratory procedures, and embryo transfer (ET), including medication dosages and administration schedules based on individual patient profiles. The selection of good-quality blastocysts for transfer was based on the Gardner classification, with a wash-out period required between stimulation and ET. Outcomes of the IVF/intracytoplasmic sperm injection (ICSI) were precisely recorded, from hormone levels to the rates of fertilization, embryo development, and pregnancy confirmation via serum Human Chorionic Gonadotropin (hCG) test and transvaginal ultrasound for gestational sac (GS) detection.

    Statistical analysis aimed to explore the relationship between patient background, dietary and exercise habits, FertiQoL scores, and IVF outcomes, using a multivariable approach to identify significant factors. The study attempted to recruit 286 patients to detect a clinically relevant difference in the primary outcome, the good-quality blastocyst rate, with comprehensive statistical analysis performed using SAS software.

    Study results 

    Between May 2019 and March 2022, 291 women seeking their first IVF treatment at clinics within the IVF Japan Group and the University of Tokyo Hospital were initially considered for the study. After excluding those who discontinued treatment, became pregnant spontaneously, or met exclusion criteria, 281 women proceeded with controlled ovarian stimulation and oocyte retrieval. Various reasons, including lack of fertilization, absence of good-quality embryos, and loss of follow-up, further narrowed the participants to 260 who underwent ET, with 200 undergoing single blastocyst embryo transfers (blast-SETs). Of these, 139 women showed positive hCG levels, indicating pregnancy, and in 121 women, a single GS was detected without instances of multiple GSs.

    The study examined the rate of good-quality blastocysts per oocyte retrieval, revealing that women over 36 years old or those with Hashimoto’s disease had significantly lower rates, while frequent fish consumption was also tentatively linked to lower rates. Analysis of all ET cycles showed that older women had lower chances of a positive pregnancy test. In contrast, adequate sleep, computer use, and non-smoking partners were associated with higher chances. GS detection post-ET was more likely with the use of olive oil, more prolonged computer use, and a body mass index (BMI) of 20.8  kg/m2 or higher, with older age decreasing the likelihood.

    Explicitly focusing on blast-SET cycles, computer use for four or more hours a day significantly improved the chances of a positive pregnancy test and GS detection. Older age tended to decrease the likelihood of a positive pregnancy test, while a higher FertiQoL Total scaled treatment score and a certain BMI threshold appeared to favor GS detection, however, with a trend towards significance rather than definitive proof.

    Conclusions 

    To summarize, the study explored the effects of lifestyle, dietary habits, and fertility-specific QoL on ART outcomes among Eastern Asian women. Key findings include the negative impacts of advanced age and Hashimoto’s disease on blastocyst quality and positive associations between adequate sleep, computer use, and pregnancy success. Olive oil consumption emerged as beneficial for gestational sac detection, challenging assumptions about dietary impacts on fertility. Notably, male smoking negatively affected outcomes, highlighting the importance of lifestyle factors in reproductive success. 

    [ad_2]

    Source link

  • Feds join ranks of employers with generous fertility benefits

    Feds join ranks of employers with generous fertility benefits

    [ad_1]

    Companies have increasingly offered generous fertility benefits to attract and keep top-notch workers. Now, the federal government is getting in on the act. Starting this year, federal employees can choose plans that cover several fertility services, including up to $25,000 annually for in vitro fertilization procedures and up to three artificial insemination cycles each year.

    With about 2.1 million civilian employees, the federal government is the nation’s largest employer. Now, just as businesses of every stripe prioritize fertility benefits, in vitro fertilization — a procedure in use for more than 40 years — has become a tricky topic for some anti-abortion Republican members of Congress and even presidential candidates.

    It was inevitable that disagreements over IVF among abortion opponents would eventually break into the open, said Mary Ziegler, a legal historian and expert on reproductive health.

    “The anti-abortion movement from the 1960s onward has been a fetal personhood movement,” said Ziegler, a law professor at the University of California-Davis. Since the U.S. Supreme Court’s Dobbs decision eliminated the constitutional right to abortion, anti-abortion groups and the Republican Party are grappling with what “fetal personhood” means and how that fits into their position on IVF and other technologies that help people have babies.

    The Alabama Supreme Court set the stage for the recent brouhaha with a ruling last month that frozen embryos created through IVF are children under state law. A pair of Democratic senators advanced legislation that would override state laws by establishing a statutory right to access IVF and other such technologies. The bill was blocked on the Senate floor by a Republican opponent.

    These events highlight the tough spot in which Republicans find themselves. Many support IVF, and they are keenly aware that it’s extremely popular: 86% of adults in a recent CBS News-YouGov poll said IVF should be legal. The outcry over the Alabama ruling and Republicans’ inability to coalesce around a federal response, however, has exposed fault lines in the party.

    Some anti-abortion groups have strenuously objected to measures like that Senate bill, arguing that lawmakers must balance IVF with the responsibility to respect life.

    Republicans “are trying to finesse it, which is very hard,” Ziegler said.

    About 10% of women and men face fertility problems, according to the National Institute of Child Health and Human Development. IVF, a process in which an egg is fertilized in a laboratory and later implanted in the uterus, is among the most expensive fertility treatments, costing about $20,000 for one round. Even with insurance coverage, the procedure is pricey, but for some people it’s the only way to conceive.

    In recent years, the number of companies offering fertility benefits to employees has grown steadily. In the early 2000s, fewer than a quarter of employers with at least 500 workers covered IVF, according to benefits consultant Mercer’s annual employer survey. In 2023, that figure had roughly doubled, to 45%. Employers typically cap IVF benefits. In 2023, employers had a median lifetime maximum benefit of $20,000 for IVF, according to the Mercer survey.

    The federal government’s IVF benefit — paying up to $25,000 a year — is more generous than that of a typical employer. Coverage is available through the popular Blue Cross and Blue Shield Federal Employee Program’s standard option. Altogether, two dozen 2024 health plans for federal workers offer enhanced IVF coverage, with varying benefits and cost sharing, according to the federal Office of Personnel Management, which manages the federal health plans.

    “OPM’s mission is to attract and retain the workforce of the future,” said Viet Tran, OPM’s press secretary, in written answers to questions. He noted that surveys have found that federal health benefits have influenced employees’ decisions to stay with the federal government.

    Starting this year, plans offered to federal employees are required to offer fertility benefits, according to OPM.

    But it’s unclear how the emerging political debate surrounding IVF and other reproductive health issues could affect national benefit and coverage trends.

    Last month, after the Alabama Supreme Court ruled that frozen embryos left over following IVF procedures are considered children under state law, the state legislature quickly passed and Republican Gov. Kay Ivey signed a bill that grants immunity to patients and providers who participate in IVF services. During the ensuing dust-up, a coalition of more than a dozen anti-abortion groups signed a letter drawing a clear line in the sand. “Both science and logic have made it clear that embryos must be accorded the same human rights” as other human beings, it read. The Alabama law didn’t address the underlying issue of the “personhood” of the embryos, leaving open the door for further litigation and potential restrictions on IVF in Alabama and other states, some legal analysts say.

    More than a third of states have laws on the books that classify fetuses as people at some stage of pregnancy, according to an analysis by Politico.

    It’s unclear whether the turmoil surrounding the Alabama case will have long-term repercussions for employee benefits there or in other states.

    “If this were something that were to happen in multiple states, employers would have to figure out how to navigate around that,” said Jim Winkler, chief strategy officer of the Business Group on Health, a nonprofit that represents the interests of large employers. At this point, employers will want to keep a watchful eye on the issue but probably not plan any changes, Winkler said.

    A Mercer blog post advised businesses with Alabama employees to review health plan policies related to medical travel and leave benefits. Further, “employers should monitor other states that broadly define fetal personhood and restrict reproductive healthcare,” the blog post advised.

    The situation is reminiscent of what happened with abortion coverage following the Supreme Court’s Dobbs decision in 2022. As states imposed restrictions on access to abortions, many companies began providing travel expenses for their workers to seek them.

    But what happened with abortion may not be a good predictor of what will happen with IVF, said Dorianne Mason, director of health equity at the National Women’s Law Center.

    Following the Alabama judge’s ruling, “the legislature in Alabama moved so quickly to respond to the outcry,” Mason said. “When we look at the legislative response to IVF, it’s moving in a markedly different direction on access to care” than has occurred with other types of reproductive care.




    Kaiser Health NewsThis article was reprinted from khn.org, a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF – the independent source for health policy research, polling, and journalism.

    [ad_2]

    Source link

  • IVF solutions could help address the falling birth rates among UK’s aging population

    IVF solutions could help address the falling birth rates among UK’s aging population

    [ad_1]

    With the UK’s birth rate falling, more awareness and support are needed for people struggling or putting off starting a family to ensure future generations.

    The Department of Health and Social Care recently reported that more must be done to adapt for the onset of the UK’s ageing population. With an ageing population comes a myriad of social and economic challenges – many of which need to be addressed as early as possible.

    Many people have put starting a family on hold, whether it be due to fertility factors outside of their control, or due to a wish to delay until they have that foothold. Fertility, however, does not wait for all, and thus more fertility and IVF offerings are helpful in reducing concerns they don’t need when planning for their dream family. 

    “Fertility care and developments in assisted reproduction technologies are increasingly important in a society that is slowly skewing towards an ageing population,” says James Barr, Managing Director of Bridge Clinic London. 

    When foregoing family life in the past, many chose to pursue career opportunities or other factors. It’s important to remember that patients can have both options available – family life and a career – to them if they know where to look.”

    James Barr, Managing Director, Bridge Clinic London

    “Britain’s ageing population is a concern that does requires action now before its effects are irreversible. We are all living longer, and that’s a testament to modern medicine. But combine this with a falling national birth rate, and society will soon encounter problems.”

    Barr believes clinics also have a responsibility to raise awareness for people struggling with finding the right care option. “People who may have either put an end to starting a family or have delayed the process can speak to an IVF partner to discuss their options and potentially a more accessible offering they might have previously not been aware of. For those seeking alternative routes to starting a family, simply having an introductory conversation with clinician could spark the beginning of a journey towards parenthood, as without this consultation they often feel they have lost hope or believe their budget cannot accommodate it.

    “Advancements in IVF solutions such as egg storage and sperm donation are now available to help patients who may feel that now is not the right time to start or extend their family or may be unsure. Transparency of fertility options and their costs, including potential add-on treatments, should be clear from the onset to build needed trust with potential patients who may be experiencing uncertainty and emotional pressures.

    “Starting a family can be expensive and issues around childcare costs have been making headlines which could be steering patients away from starting a family. Affordable and accommodating IVF options being available is the first step to address this, now it is time for the government to implement reassurances for patients that the next step – specifically, childcare costs – will be prevented from spiralling beyond control.”

    Barr concludes: “A falling birth rate is a difficult challenge for any society to combat and overcome, but there are always solutions. Building the foundations of trust and reassuring patients that IVF is an affordable and accommodating process to start a family.

    “In years gone by, an ageing population would be difficult to overturn. Today, fertility clinics are on-hand to encourage people who are either struggling or unsure about starting a family and help gradually address the issue of an ageing population.”

    [ad_2]

    Source link

  • Roundtables – Future of Families: How reproductive technology can reverse population decline

    Roundtables – Future of Families: How reproductive technology can reverse population decline

    [ad_1]

    Future of Families: How reproductive technology can reverse population decline

    Speakers: Antonio Regalado, Sr Editor of biomedicine and special guest Martín Varsavsky, Founder of Prelude Fertility

    Birth rates have been plummeting in wealthy countries, well below the “replacement” rate. Even in China, a dramatic downturn in the number of babies has officials scrambling, as its population growth turns negative. What’s behind the baby bust and can new reproductive technology reverse the trend? Startup companies are working on ways to reduce the cost of IVF, allow same-sex couples to reproduce, and extend parenthood far later into life.

    Related Coverage

    [ad_2]

    Source link

  • If you’re poor, fertility treatment can be out of reach

    If you’re poor, fertility treatment can be out of reach

    [ad_1]

    Mary Delgado’s first pregnancy went according to plan, but when she tried to get pregnant again seven years later, nothing happened. After 10 months, Delgado, now 34, and her partner, Joaquin Rodriguez, went to see an OB-GYN. Tests showed she had endometriosis, which was interfering with conception. Delgado’s only option, the doctor said, was in vitro fertilization.

    “When she told me that, she broke me inside,” Delgado said, “because I knew it was so expensive.”

    Delgado, who lives in New York City, is enrolled in Medicaid, the federal-state health program for low-income and disabled people. The roughly $20,000 price tag for a round of IVF would be a financial stretch for lots of people, but for someone on Medicaid — for which the maximum annual income for a two-person household in New York is just over $26,000 — the treatment can be unattainable.

    Expansions of work-based insurance plans to cover fertility treatments, including free egg freezing and unlimited IVF cycles, are often touted by large companies as a boon for their employees. But people with lower incomes, often minorities, are more likely to be covered by Medicaid or skimpier commercial plans with no such coverage. That raises the question of whether medical assistance to create a family is only for the well-to-do or people with generous benefit packages.

    “In American health care, they don’t want the poor people to reproduce,” Delgado said. She was caring full-time for their son, who was born with a rare genetic disorder that required several surgeries before he was 5. Her partner, who works for a company that maintains the city’s yellow cabs, has an individual plan through the state insurance marketplace, but it does not include fertility coverage.

    Some medical experts whose patients have faced these issues say they can understand why people in Delgado’s situation think the system is stacked against them.

    “It feels a little like that,” said Elizabeth Ginsburg, a professor of obstetrics and gynecology at Harvard Medical School who is president-elect of the American Society for Reproductive Medicine, a research and advocacy group.

    Whether or not it’s intended, many say the inequity reflects poorly on the U.S.

    “This is really sort of standing out as a sore thumb in a nation that would like to claim that it cares for the less fortunate and it seeks to do anything it can for them,” said Eli Adashi, a professor of medical science at Brown University and former president of the Society for Reproductive Endocrinologists.

    Yet efforts to add coverage for fertility care to Medicaid face a lot of pushback, Ginsburg said.

    Over the years, Barbara Collura, president and CEO of the advocacy group Resolve: The National Infertility Association, has heard many explanations for why it doesn’t make sense to cover fertility treatment for Medicaid recipients. Legislators have asked, “If they can’t pay for fertility treatment, do they have any idea how much it costs to raise a child?” she said.

    “So right there, as a country we’re making judgments about who gets to have children,” Collura said.

    The legacy of the eugenics movement of the early 20th century, when states passed laws that permitted poor, nonwhite, and disabled people to be sterilized against their will, lingers as well.

    “As a reproductive justice person, I believe it’s a human right to have a child, and it’s a larger ethical issue to provide support,” said Regina Davis Moss, president and CEO of In Our Own Voice: National Black Women’s Reproductive Justice Agenda, an advocacy group.

    But such coverage decisions — especially when the health care safety net is involved — sometimes require difficult choices, because resources are limited.

    Even if state Medicaid programs wanted to cover fertility treatment, for instance, they would have to weigh the benefit against investing in other types of care, including maternity care, said Kate McEvoy, executive director of the National Association of Medicaid Directors. “There is a recognition about the primacy and urgency of maternity care,” she said.

    Medicaid pays for about 40% of births in the United States. And since 2022, 46 states and the District of Columbia have elected to extend Medicaid postpartum coverage to 12 months, up from 60 days.

    Fertility problems are relatively common, affecting roughly 10% of women and men of childbearing age, according to the National Institute of Child Health and Human Development.

    Traditionally, a couple is considered infertile if they’ve been trying to get pregnant unsuccessfully for 12 months. Last year, the ASRM broadened the definition of infertility to incorporate would-be parents beyond heterosexual couples, including people who can’t get pregnant for medical, sexual, or other reasons, as well as those who need medical interventions such as donor eggs or sperm to get pregnant.

    The World Health Organization defined infertility as a disease of the reproductive system characterized by failing to get pregnant after a year of unprotected intercourse. It terms the high cost of fertility treatment a major equity issue and has called for better policies and public financing to improve access.

    No matter how the condition is defined, private health plans often decline to cover fertility treatments because they don’t consider them “medically necessary.” Twenty states and Washington, D.C., have laws requiring health plans to provide some fertility coverage, but those laws vary greatly and apply only to companies whose plans are regulated by the state.

    In recent years, many companies have begun offering fertility treatment in a bid to recruit and retain top-notch talent. In 2023, 45% of companies with 500 or more workers covered IVF and/or drug therapy, according to the benefits consultant Mercer.

    But that doesn’t help people on Medicaid. Only two states’ Medicaid programs provide any fertility treatment: New York covers some oral ovulation-enhancing medications, and Illinois covers costs for fertility preservation, to freeze the eggs or sperm of people who need medical treatment that will likely make them infertile, such as for cancer. Several other states also are considering adding fertility preservation services.

    In Delgado’s case, Medicaid covered the tests to diagnose her endometriosis, but nothing more. She was searching the internet for fertility treatment options when she came upon a clinic group called CNY Fertility that seemed significantly less expensive than other clinics, and also offered in-house financing. Based in Syracuse, New York, the company has a handful of clinics in upstate New York cities and four other U.S. locations.

    Though Delgado and her partner had to travel more than 300 miles round trip to Albany for the procedures, the savings made it worthwhile. They were able do an entire IVF cycle, including medications, egg retrieval, genetic testing, and transferring the egg to her uterus, for $14,000. To pay for it, they took $7,000 of the cash they’d been saving to buy a home and financed the other half through the fertility clinic.

    She got pregnant on the first try, and their daughter, Emiliana, is now almost a year old.

    Delgado doesn’t resent people with more resources or better insurance coverage, but she wishes the system were more equitable.

    “I have a medical problem,” she said. “It’s not like I did IVF because I wanted to choose the gender.”

    One reason CNY is less expensive than other clinics is simply that the privately owned company chooses to charge less, said William Kiltz, its vice president of marketing and business development. Since the company’s beginning in 1997, it has become a large practice with a large volume of IVF cycles, which helps keep prices low.

    At this point, more than half its clients come from out of state, and many earn significantly less than a typical patient at another clinic. Twenty percent earn less than $50,000, and “we treat a good number who are on Medicaid,” Kiltz said.

    Now that their son, Joaquin, is settled in a good school, Delgado has started working for an agency that provides home health services. After putting in 30 hours a week for 90 days, she’ll be eligible for health insurance.

    One of the benefits: fertility coverage.




    Kaiser Health NewsThis article was reprinted from khn.org, a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF – the independent source for health policy research, polling, and journalism.

    [ad_2]

    Source link

  • House of Lords committee opens call for evidence on prevention and consequences of preterm birth

    House of Lords committee opens call for evidence on prevention and consequences of preterm birth

    [ad_1]

    The House of Lords Preterm Birth Committee has published its call for evidence as part of its inquiry looking into the prevention, and consequences, of preterm birth.

    The Committee is seeking evidence on a number of topics, including:

    • treatments and interventions that can assist in the prediction and prevention of preterm birth;
    • neonatal and longer-term care and support for babies born preterm;
    • existing clinical guidance relating to preterm birth, and how this is implemented;
    • the ethnic and socioeconomic inequalities seen in relation to preterm birth, and how these could be reduced;
    • priority areas for research to prevent preterm birth and improve care for mothers and babies.

    Members of the committee include; Lord Patel (obstetrician), Lord Winston (IVF pioneer), Baroness Watkins of Tavistock (Emeritus Professor of Nursing), and Baroness Cumberlege (former Under-Secretary of State for Health), and Baroness Wyld (Lords sponsor of the Neonatal Care (Leave and Pay) Act 2023.)

    Preterm birth affects around 8% of live births in England each year, and it can have serious and long-term consequences. It is the single biggest cause of neonatal mortality and morbidity in the UK.

    The Government has set an ambition to reduce the preterm birth rate to 6% of live births by 2025. Our inquiry will examine how preterm births can be prevented and their impact reduced, and whether Government policy is adequate to meet its target.

    We are keen to hear from parents with lived experience of preterm birth, health professionals, academics, charities, and professional organizations to ensure all views are considered.”

    Lord Patel, Chair, Preterm Birth Committee

    The complete list of questions, plus details of how to submit evidence by the deadline of Wednesday 27 March 2024, can be found on the committee’s website.

    [ad_2]

    Source link